脓毒症与急性呼吸窘迫综合征精准医学研究议程:美国胸科学会官方研究声明
美国胸科学会资助多学科工作组,通过文献综述与概念框架迭代制定脓毒症和ARDS精准医学研究议程。工作组提出六项优先推荐,涵盖知识网络建设、新型试验设计、数据科学创新、实时工具开发、公平可及性及可持续资金支持。精准医学方法或可改善脓毒症和ARDS患者的个体化治疗。
要点
- 建立脓毒症和ARDS的大型深度表型与 harmonized 知识网络。
- 实施适应性设计等新型试验,并将试验流程嵌入电子健康记录。
- 确保精准医学策略适用于不同种族、民族、社会经济和人口群体。
核心结论
- 整合基因组、生物学和环境因素变异的精准医学方法,可能为脓毒症和ARDS患者提供更好的个体化治疗并改善照护。
研究设计与样本
- 美国胸科学会董事会资助,多学科多样性工作组审查文献并建立概念框架,迭代制定精准医学研究议程推荐。
主要发现
- 工作组提出六项优先推荐:建立大型深度表型与 harmonized 知识网络;实施适应性设计等新型试验并将流程嵌入电子健康记录;持续创新识别治疗效应异质性的数据科学与工程方法;开发实时应用精准医学方法的工具;确保精准医学策略适用于不同种族、民族、社会经济和人口群体;确保充足可持续的资金。
临床怎么用
- 临床可关注精准医学策略在脓毒症和ARDS个体化治疗中的应用,并参与相关数据网络与新型试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Precision medicine focuses on the identification of therapeutic strategies that are effective for a group of patients based on similar unifying characteristics. The recent success of precision medicine in non-critical care settings has resulted from the confluence of large clinical and biospecimen repositories, innovative bioinformatics, and novel trial designs. Similar advances for precision medicine in sepsis and in the acute respiratory distress syndrome (ARDS) are possible but will require further investigation and significant investment in infrastructure. Methods: This project was funded by the American Thoracic Society Board of Directors. A multidisciplinary and diverse working group reviewed the available literature, established a conceptual framework, and iteratively developed recommendations for the Precision Medicine Research Agenda for Sepsis and ARDS. Results: The following six priority recommendations were developed by the working group: 1) the creation of large richly phenotyped and harmonized knowledge networks of clinical, imaging, and multianalyte molecular data for sepsis and ARDS; 2) the implementation of novel trial designs, including adaptive designs, and embedding trial procedures in the electronic health record; 3) continued innovation in the data science and engineering methods required to identify heterogeneity of treatment effect; 4) further development of the tools necessary for the real-time application of precision medicine approaches; 5) work to ensure that precision medicine strategies are applicable and available to a broad range of patients varying across differing racial, ethnic, socioeconomic, and demographic groups; and 6) the securement and maintenance of adequate and sustainable funding for precision medicine efforts. Conclusions: Precision medicine approaches that incorporate variability in genomic, biologic, and environmental factors may provide a path forward for better individualizing the delivery of therapies and improving care for patients with sepsis and ARDS.
引用
- Shah FA, Meyer NJ, Angus DC, et al. A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021. PMID: 34652268. doi:10.1164/rccm.202108-1908ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。